# Refining Treatment Options for Trichomonas Vaginalis Infection: A Comparative Analysis of Metronidazole and Secnidazole

> **NCT06261840** · PHASE4 · RECRUITING · sponsor: **Tulane University** · enrollment: 1200 (estimated)

## Conditions studied

- Trichomonas Vaginitis
- Bacterial Vaginitis

## Interventions

- **DRUG:** Metronidazole 500 mg
- **DRUG:** Secnidazole 2000 MG

## Key facts

- **NCT ID:** NCT06261840
- **Lead sponsor:** Tulane University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-06
- **Primary completion:** 2029-05-01
- **Final completion:** 2029-07-31
- **Target enrollment:** 1200 (ESTIMATED)
- **Last updated:** 2026-05-06

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06261840

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06261840, "Refining Treatment Options for Trichomonas Vaginalis Infection: A Comparative Analysis of Metronidazole and Secnidazole". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT06261840. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*